Pierluigi Celerino

Azienda USL di Bologna

Papers

2

Total Citations

3

H-Index

1

About

Pierluigi Celerino is a leading figure in the surgical management of deep endometriosis, with a focused expertise in the comparative effectiveness of robotic-assisted surgical (RAS) platforms. His major contributions center on advancing minimally invasive techniques to improve patient outcomes in complex gynecologic surgery. Celerino spearheaded the landmark "Clash of the Titans" study, the first multi-center retrospective comparative analysis between the da Vinci and Hugo™ RAS systems for treating deep endometriosis. This work, already garnering 2 citations, rigorously compared validated patient-reported outcomes—including bladder function (BFLUTS), bowel function (KESS), and quality of life (GIQLI)—alongside pain symptom changes, revealing significant differences between the two robotic platforms. Additionally, his 2025 investigation into the correlation between the AAGL 2021 classification and perioperative complications in endometriosis surgery provides a critical framework for risk stratification. Through these studies, Celerino is not only refining surgical technique but also establishing evidence-based benchmarks for robotic surgery in endometriosis care, directly impacting how surgeons select technology and counsel patients. His work is essential reading for researchers and clinicians seeking to optimize surgical outcomes in this challenging field.

Research Focus

Key Achievements

1
H-Index
2
Papers
3
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Clash of the Titans: the first multi-center retrospective comparative study between da Vinci and Hugo <sup>™</sup> RAS surgical systems for the treatment of deep endometriosis
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Azienda USL di Bologna

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago